- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01177865
Study of Treatment Choice in Patients With Localized Prostate Cancer
Evaluating Patient Preferences for the Treatment of Localized Prostate Cancer - A Discrete Choice Experiment
RATIONALE: Gathering information about patients with prostate cancer may help doctors learn more about how patients choose treatment options.
PURPOSE: This study is looking at treatment choice in patients with localized prostate cancer.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
OBJECTIVES:
Primary
- To evaluate the importance of prostate cancer treatment characteristics to men with localized prostate cancer.
- To determine to what extent men will choose the strengths and weaknesses of one treatment over a different set of strengths and weaknesses of another treatment when making a choice between them.
Secondary
- To determine the correlation between attributes that are important to men and baseline demographics, functional status, and disease risk characteristics.
OUTLINE: This is a multicenter study.
Patients complete a 'discrete choice experiment' questionnaire presenting three treatment options based on 8 aspects of treatment. Attributes relevant to men with prostate cancer (e.g., sexual health, urinary function, return to normal activities [work, gardening, sports, shopping]) that apply to surveillance, radical therapies and new minimally-invasive therapies have been selected for consideration. Baseline demographics such as age, working/retired/unemployed/household income, prostate cancer characteristics (PSA level, Gleason grade, stage), baseline functional status (genitourinary function), and final treatment choice will also be collected in order to ascertain whether there is any relationship and association between patient preferences for treatment and these baseline demographics. Individuals will be asked to choose between the three treatment profiles.
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
England
-
London, England, Storbritannien, WIT 3AA
- Rekrytering
- University College of London Hospitals
-
Kontakt:
- Contact Person
- Telefonnummer: 44-20-7380-9194
- E-post: markemberton1@btinternet.com
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
DISEASE CHARACTERISTICS:
Histological diagnosis of adenocarcinoma of the prostate on transrectal or transperineal template prostate biopsies
Clinical stage ≤ T2c N0 M0 (radiological T3a allowed)
- Local staging imaging as per guidelines to demonstrate localized disease (e.g., MRI, CT, and/or bone scan)
- No metastatic disease or nodal disease outside the prostate on bone scan or cross-sectional imaging
- No prior prostate surgery for cancer control (e.g., radical prostatectomy, high-intensity focused ultrasound ablation, cryosurgery, or photodynamic therapy) or other treatment for prostate cancer
- Gleason grade ≤ 7
- Serum PSA ≤ 15 ng/mL
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
- No prior radiotherapy
- No androgen suppression/hormone treatment within the previous 12 months for prostate cancer
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
Vad mäter studien?
Primära resultatmått
Resultatmått |
---|
Preferences for, and trade-offs between, the attributes of pre-treatment evaluation with general anaesthetic biopsies and post-treatment frequency of biopsies
|
Treatment choice in respect to risks to sexual function and urinary function, return to normal activities, aim to treat the whole gland or only cancer areas or important cancer areas, retreatment rate, and mortality rate
|
Sekundära resultatmått
Resultatmått |
---|
Correlation between attributes important to men and baseline demographics, functional status, and disease risk characteristics
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Mark Emberton, MD, FRCS, MBBS, University College London Hospitals
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- CDR0000682206
- UCL-COMPARE
- EU-21055
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på enkätadministration
-
Catholic University of the Sacred HeartAvslutadLivskvalité | Kirurgiskt sår | Biopsisår | Läka kirurgiska sårItalien
-
Korea United Pharm. Inc.AvslutadDiabetes mellitus, typ 2Korea, Republiken av
-
Korea United Pharm. Inc.AvslutadGERDKorea, Republiken av
-
Boston UniversityNational Heart, Lung, and Blood Institute (NHLBI)Avslutad
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...The Leeds Teaching Hospitals NHS Trust; University of Leeds; European Organisation... och andra samarbetspartnersHar inte rekryterat ännuCancer | Palliativ vård | ÖverlevnadUngern, Italien, Frankrike, Storbritannien, Nederländerna, Estland, Serbien, Litauen, Slovenien, Albanien, Österrike, Belgien, Bulgarien, Kroatien, Cypern, Tjeckien, Danmark, Finland, Georgien, Tyskland, Grekland, Irland, Lettland, Moldavien... och mer
-
Lukas Biomedical Inc.Virginia Contract Research Organization Co., Ltd.RekryteringHepatocellulärt karcinomTaiwan
-
University of EdinburghBritish Heart FoundationAvslutad
-
Fondazione Don Carlo Gnocchi OnlusMeyer Children's Hospital IRCCS; Fondazione Don Carlo Gnocchi ONLUS - Centro...Rekrytering
-
Istituto Ortopedico GaleazziAvslutad
-
Gumi Cha Medical CenterAvslutadKroniska njursjukdomarKorea, Republiken av